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lication and transcription. We have assessed the global roles of histone chaperones in Saccharomy-
ces cerevisiae. Microarray transcriptional analyzes indicate that histone chaperones have their own
speciﬁc target genes, and various histone chaperones have partially overlapping functions during
transcriptional regulation. The histone deacetylase inhibitor TSA and histone chaperones Asf1,
Vps75 and Rtt106 can function in parallel pathways to regulate transcription. Moreover, TSA can
speciﬁcally antagonize histone chaperone Chz1-mediated telomere anti-silencing. This study dem-
onstrates that a mutual cross-talk mechanism exists between histone chaperones and histone
deacetylation in transcriptional regulation.
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In eukaryotic organisms, the organization of DNA into chroma-
tin has a major impact on important biological processes. The
nucleosome core particle is the fundamental repeating unit of
chromatin, containing 146 bps of DNA wrapped around a histone
octamer, which is comprised of two copies each of four histone
proteins [1]. The chromatin structure is highly dynamic, facilitating
DNA-related processes such as transcription, replication, recombi-
nation and DNA repair [2]. The dynamic properties of chromatin
are tightly controlled by regulatory mechanisms including cova-
lent modiﬁcation of histones, chromatin remodeling, incorporation
of histone variants and DNA methylation [3].
Emerging evidence has led to the realization that histone chap-
erones are central factors for a variety of chromatin processes [4].
Although histone chaperones were originally implicated in aiding
nucleosome assembly, it has become clear that histone chaperones
play major roles in a variety of chromatin transactions, such as his-
tone storage, translocation to the nucleus and histone exchange.
Histone chaperones are classiﬁed by their selective binding proper-
ties, which include the highly conserved H2A/H2B chaperones
Nap1, FACT, nucleophosmin, nucleoplasmin and nucleolin [5,6],chemical Societies. Published by E
Y. Wan).and the H3/H4 chaperones Asf1, HIRA, CAF-1 and Spt6 [5,6]. Di-
verse histone chaperones can coordinate the delicate balance be-
tween nucleosome assembly and reassembly in the maintenance
of chromatin dynamics [7].
Post-translational modiﬁcations of histones can dynamically
change chromatin structure and plays a signiﬁcant role in various
DNA-related processes. Histone acetylation is one of the best char-
acterized post-translational modiﬁcations of histones and depends
on the balance of activities of two enzymes, histone acetyltransfer-
ase (HAT) and histone deacetylase (HDAC) [8]. Dynamic histone
acetylation can regulate transcription, chromosome condensation,
DNA replication and DNA integrity [9]. Equilibrium between his-
tone acetylation and deacetylation plays an important role for nor-
mal cell function and the perturbation of this balance can lead to
human diseases including cancer [10]. Recently, it has been real-
ized that HDACs represent promising targets to reverse abnormal
epigenetic states related to cancer [11]. HDAC inhibitors (HDACIs),
such as trichostatin A (TSA), globally increase levels of histone
acetylation in chromatin and also induce different anti-cancer ef-
fects in vitro and in vivo [12].
The DNA replication-coupled nucleosome assembly pathway is
mediated by speciﬁc histone chaperones. Chromatin assembly fac-
tor 1 (CAF-1) preferentially deposits newly synthesized H3 and H4
onto replicating DNA, a process which is mediated by interactions
between CAF-1 and two H3–H4 histone chaperones, Asf1 andlsevier B.V. All rights reserved.
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tone H3 and H4 are acetylated prior to their assembly into nucleo-
somes [14]. Acetylation of H3 lysine 56 (H3K56Ac) can enhance
thebindingofH3withhistone chaperonesCAF-1andRtt106 to facil-
itate nucleosomeassembly during S phase of the cell cycle [14]. Bud-
ding yeast lacking Asf1 showed greatly reduced levels of acetylation
on lysine 9 of histone H3 [15]. Proteomic surveys have revealed that
histone chaperone Asf1 and Nap1 can mediate both H3 deacetyla-
tion and H3K4me3 demethylation [4]. A recent study also demon-
strated that Asf1/HIRA can facilitate global histone deacetylation
[16]. These data reveal a level of crosstalk between histone chaper-
ones and histone deacetylation during gene regulation.
Chz1 is a histone chaperone that shows a preference for H2AZ–
H2B over H2A–H2B and cooperates with the SWR1 complex in the
exchange of H2A for Htz1p [17]. The histone chaperone Nap1 can
bind H2A–H2B dimers and (H3–H4)2 tetramers with similar high
afﬁnity and promotes nucleosome assembly by eliminating non-
nucleosomal histone DNA interactions [18]. Asf1, a conserved his-
tone H3/H4 chaperone, can assemble and disassemble nucleosomes
and promote histone acetylation [19]. Vps75 belongs to the NAP
domain family of histone chaperones and can combine with ATP-
dependent chromatin remodeling complexes to mediate histone
exchange [20]. The Rtt106 histone chaperone interacts physically
and functionally with the chromatin assembly factor-1 for replica-
tion-coupled nucleosomal deposition [21].
Eukaryotic genomes are grouped into two distinct and
exchangeable chromatin structures known as euchromatin and
heterochromatin. The genome of S. cerevisiae contains three het-
erochromatin-like classes of loci which include the mating type
loci, the rDNA regions and subtelomeric regions. These well char-
acterized regions have been used to gain signiﬁcant insight into
the molecular mechanism of gene silencing [22]. Boundaries be-
tween euchromatin and heterochromatin have been strongly
linked with chromatin structure and the status of histone acetyla-
tion is associated with boundary formation [23,24]. The histone
acetyltransferase complex SAS-I globally acetylates H4K16 in subt-
elomeric regions and histone deacetylase Rpd3 can provide global
chromatin deacetylation. Deletions of genes encoding the SAS-I
subunit SAS2, SAS4, or SAS5 changes the distribution of Sir proteins
and results in silencing defects [25,26]. Deletion of RPD3 leads to
SIR spreading and repression of subtelomeric genes [24]. These
observations imply that the dynamic modiﬁcations of histone acet-
ylation are central for the formation of boundaries in the genome.
Although signiﬁcant advances have been made in understanding
the function of histone chaperones and TSA on histone (de)acetyla-
tion, little is known about the relationships between histone chap-
erones and TSA. In this study, we have used DNA microarray
analyzes to proﬁle the transcriptomes of ﬁve different histone
chaperone mutants. We showed that individual histone chaper-
ones can regulate distinct subsets of target genes. Interestingly,
TSA treatment and chz1 deletion mutations can antagonize each
other’s effects on transcriptional regulation. Our results suggest
that histone chaperones and histone deacetylation interact in a
complex manner to regulate gene expression.
2. Materials and methods
2.1. Strains and growth conditions
All yeast strains used in this study are listed in Table S1. The
CHZ1, NAP1, ASF1, VPS75 and RTT106 genes were deleted individu-
ally by homologous recombination in BY4742 (WT) using a previ-
ously described PCR-based procedure [27]. The deletion strains
were veriﬁed to be correct by PCR analysis. The strains were cul-
tured at 30 C in YPD (1% yeast extract, 2% peptone, 2% glucose)media. For TSA treatments, WT and deletion mutants were grown
to mid-log phase (OD600 = 0.5), TSA (Sigma–Aldrich) was then
added to the yeast cultures at a ﬁnal concentration of 10 lM and
cells were cultured for additional hour. The cells were collected
and directly frozen in liquid nitrogen.
2.2. RNA preparation
Total RNA was isolated by the hot acid phenol extraction proto-
col as previously described [27]. Brieﬂy, cell pellets were resus-
pended in TES buffer (50 mM Tris–HCl, pH 7.5, 10 mM EDTA, 1%
SDS). The mixture was incubated at 65 C for 1 h with vigorous vor-
texing every 10 min for 5 s. The aqueous layer was separated by
centrifugation at 15 000 rpm for 10 min and extracted with an
equal volume of chloroform. The total RNA was further puriﬁed
with a Qiagen RNeasy kit and analyzed with an Agilent Bioanalyzer
to verify integrity, and in the spectrophotometer for quantiﬁcation.
Two independent cultures of each strain were prepared as biolog-
ical replicates for total RNA isolation analysis on DNA microarrays.
2.3. Microarray and data analysis
Microarray labeling and hybridization reactions were per-
formed as previously described [27,28]. Two color microarrays,
comparing RNA from the experimental conditions (deletion muta-
tions grown in YPD, WT and deletion mutations grown in YPD with
TSA treatment) to RNA from the control WT cells grown in glucose-
containing medium (YPD), were performed using Agilent whole-
genome S. cerevisiae arrays. Log2 of the average mRNA abundance
ratios are reported. Differentially expressed genes were identiﬁed
by maximum-likelihood analysis and signiﬁcantly affected genes
in the experimental conditions were identiﬁed by a change in
expression of twofold or more compared to the expression in the
relevant WT strains. Signiﬁcantly differentially expressed genes
were analyzed as previously described [28] by using Excel (Micro-
soft) for chromosome position analysis.
2.4. Chromatin immunoprecipitation
ChIP analyzes were performed as described previously [27].
Chromatin was isolated and incubated with an anti-myc antibody.
The puriﬁed ChIP samples were used for qPCR analysis. Real-time
qPCR was performed by using an iCycler instrument (ABI 7900)
and a DyNAmo Flash SYBR green qPCR kit. The average of results
from three independent replicates is reported as the relative
ampliﬁcation of each target of interest compared to a normaliza-
tion control amplicon within the non-promoter IGRi YMR325W.
The occupancy level was determined by dividing the relative abun-
dance of an experimental target by the relative abundance of a
control target. This ratio represents the enrichment of ChIP DNA
over the input DNA for a speciﬁc target versus the control. All oli-
gonucleotide sequences are listed in Supplementary Table S1.
2.5. Accession numbers
The Gene Expression Omnibus accession number for the micro-
array data reported in this paper is GSE30228.
3. Results and discussion
3.1. Deletion of speciﬁc histone chaperones leads to misregulation of
distinct subsets of genes
As showed for FACT, it is the chromatin structure unique to each
gene that determines the dependence on a speciﬁc chaperone to
Y. Wan et al. / FEBS Letters 585 (2011) 2519–2525 2521maintain the integrity of chromatin structure during transcription
[29–31]. Consequently we expected that the absence of different
histone chaperones would affect distinct subsets of genes which
have different patterns of chromatin structures. Transcriptome
proﬁling was used to obtain a global understanding of how differ-
ent histone chaperones contribute to chromatin regulation.
We compared the global steady-state mRNA levels of logarith-
mically growing WT and individual histone chaperones deletion
mutants using DNA microarrays (representing 6271 yeast ORFs).
This analysis yield 515, 76, 496, 204 and 460 genes that signiﬁ-
cantly increased or decreased in gene expression in the absence
of CHZ1, NAP1, ASF1, VPS75 and RTT106, respectively (Fig. 1). Except
for the chz1 mutant, most of the misregulated genes in these four
mutants are signiﬁcantly up-regulated. 70 out of 76, 487 out of
496, 188 out of 204 and 447 out of 460 are induced in the nap1,
asf1 and vps75 deletion strains, respectively. This upregulation
indicates that these histone chaperones play important roles in
transcriptional repression rather than activation for speciﬁc sub-
sets of genes in the genome. Hypergeometric tests demonstrated
that asf1 showed signiﬁcant overlap of misregulated genes with
nap1, rtt106 and vps75 (P = 4.2  108, P < 1.0  1020 and
P < 1.0  1020, respectively). Of 76 genes affected by NAP1, 29
are also affected by CHZ1. Both Chz1 and Nap1 function as histone
chaperones to deliver Htz1/H2B heterodimers to the SWR1 com-
plex [32], and we observe signiﬁcant overlap of misregulated genes
between these two mutants (P = 3.3  1013). Signiﬁcant overlap
was also observed between rtt106 and vps75 (P < 1.0  1020).Fig. 1. Comparison of genes with altered transcriptional proﬁles in chz1, nap1, asf1,
vps75 and rtt106 deletion mutants. Venn diagrams depicting the numbers of genes
affected in their transcriptional levels (>2-fold) are shown.Large scale microarray analyzes have showed that there is a corre-
lation between growth rate and genome-wide gene expression
[33]. In order to understand the transcriptional defects in different
histone chaperone mutants, we compared the growth rate be-
tween wild-type and histone chaperone mutants with and without
TSA treatment. As showed in Fig. S2, there is no signiﬁcant growth
defect in histone chaperone mutants in both YPD and YPD + TSA
plates compared with wild-type. Therefore, we concluded that
the signiﬁcant differences of transcriptional proﬁles in histone
chaperones mutants are not due to different growth rate. Collec-
tively, these data clearly demonstrate that different histone chap-
erones have speciﬁc targets across the whole genome, and they
may also have partially overlapping functions during transcrip-
tional regulation. It will be interesting to determine whether other
histone chaperones, such as Caf1, the HIR complex, FACT and Spt6
can also coordinate with each other to regulate gene expression.
3.2. Cross-talk between histone chaperones and histone deacetylation
in transcriptional regulation
To evaluate the consequences of global inhibition of histone
deacetylation on the expression of genes in yeast, we used a micro-
array approach to proﬁle transcriptomes after treatment with TSA.
Differentially expressed geneswere identiﬁed by changes in expres-
sion of twofold or more compared to expression in the relevant WT
strainwithoutTSA treatment. Bymicroarrayanalyzes,we found that
TSA can stimulate the transcription of a distinct subset of genes; 184
genes have altered their expression by at least twofold increase after
TSA treatment (Fig. 2). TSA treatment also results in the dramatic
down-regulation of a subset of genes, which is consistent with pre-
viouswork [34].Ninegenes showsigniﬁcantlydecreased expression
after TSA treatment. These nine genes, which include FRE1, FRE7,
REE1, CTR1 and IRC7 are functionally related, regulating ion storage,
uptake transport and metabolism. To validate our microarray data,
mRNA levels of FRE1, FRE7, CTR1 and IRC1 were determined by RT-
qPCR normalized to ACT1 or NUP170 and are consistent with the
microarray analyzes (Fig. S1). Although TSA has been widely ac-
cepted as a histone deacetylase inhibitor which induces gene
expression, several studies have also demonstrated that TSA treat-
ment can result in the down regulation of a subset of genes [35–37].
Taken together these results indicate that TSA treatment can
cause both transcriptional activation and repression. Although
the effects of HDAC inhibitors on transcriptional regulation are
well understood, an increasing body of evidence suggests that a
number of non-histone proteins have been identiﬁed as substrates
of HDACs, among which, transcription factors and/or transcription
regulators comprise the largest class of new targets [38–40].
Therefore, we cannot rule out the possibility that misregulated
genes upon TSA treatment are not only due to the effects of in-
creased histone acetylation.
Given that both TSA treatment and deletions of histone chaper-
ones alters the expression of subsets of genes, we question
whether there is overlap between genes whose expression is al-
tered in both TSA treated cells and histone chaperone deletion mu-
tants. Surprisingly, we found that there is signiﬁcant overlap
between WT cells treated with TSA and the asf1, vps75 and rtt106
deletion mutants (Fig. 2a). Of the 496, 204 and 460 transcripts
found signiﬁcantly altered in asf1, vps75 and rtt106 mutants,
respectively, 76, 25 and 76 unique transcripts are also found in
TSA treated WT cells. Hypergeometric analysis conﬁrmed that
TSA treatment showed a strikingly similar overlap of misregulated
genes with asf1, vps75 and rtt106 (P < 1  1020, P = 2.0  109 and
P < 1  1020, respectively). Interestingly, the histone variant chap-
erones chz1 and nap1 mutant transcriptional proﬁles do not show
signiﬁcant overlap with the transcriptional proﬁles of TSA treated
WT cells. These data demonstrate that TSA and asf1, vps75 and
Fig. 2. (a) Comparison of genes with altered transcriptional proﬁles between TSA treated WT cells and ﬁve histone chaperone null mutants. Venn diagrams depicting the
numbers of genes affected in their transcriptional levels (>2-fold) are shown. (b) Scatter plot of the Pearson correlations of transcriptional proﬁling between TSA treated WT
cells and ﬁve histone null mutants.
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subsets of genes.
Since the treatment of cells with TSA lead to strikingly similar
transcriptional proﬁles as deletions of speciﬁc histone chaperones,
we speculated that the addition of TSA to asf1, vps75 and rtt106
deletion mutants will generate similar transcriptional proﬁles to
untreated mutant cells. Consistent with our hypothesis, we ob-
served the remarkable similar features of transcriptional proﬁles
before and after TSA treatment for the histone chaperone vps75
and rtt106 mutants. Pearson correlation between their expression
proﬁles revealed high similarity with 0.83 and 0.91 for vps75 and
rtt106, respectively (Fig. 2b). The asf1mutant however, did not dis-
play the same phenotype as vps75 and rtt106. Collectively, these
results demonstrated that TSA and particular histone chaperones
can function in parallel pathways to regulate transcription.
The low Pearson correlation of transcriptional proﬁles for chz1
and nap1 before and after TSA treatment lead us to test whether
the expression of CHZ1 and NAP1 responsive genes are affected
by TSA treatment. Hierarchical cluster analyzes of ﬁve histone
chaperones mutants responsive genes are displayed in Fig. 3. Com-
parative analysis showed that majority of asf1, vps75 and rtt106
deletion responsive genes did not change their expression levels
after treated with TSA.Fig. 3. Hierarchical cluster analysis of microarray results in histone chaperone mutan
chaperone mutant with WT cells treated with TSA and histone chaperones mutants trea
heat map. Genes are ordered left to right based on relative expression levels. Red repreInterestingly the combination of TSA and chz1 or nap1 deletions
altered the transcriptional proﬁles of the chz1 or nap1 deletions. Of
210 up-regulated genes in the chz1 deletion mutant, 199 are no
longer up-regulated upon TSA treatment, with 7 of these genes
showing down-regulated transcription. Likewise, 290 out of 305
genes down-regulated in the chz1 mutant are expressed at control
levels following TSA treatment and an additional 11 genes in the
chz1 mutant switch from down- to up-regulation after TSA treat-
ment. An unanticipated class of genes identiﬁed in our microarray
experiments represents genes down-regulated in the chz1 deletion
and up-regulated by treatment with TSA that could be counter-
acted by simultaneous treatment with TSA in the chz1 mutant
strains. The nap1 deletion mutant responds to TSA treatment in a
similar way to the chz1 deletion mutants (Fig. 3). These observa-
tions suggest that TSA treatment and chz1 null mutants can coun-
teract each other’s effects on transcriptional activation and
repression.
3.3. TSA can speciﬁcally antagonize histone chaperone Chz1 mediated
telomere anti-silencing
Since TSA treatment increases global histone acetylation levels,
it is reasonable to hypothesize that TSA can also affect subtelomericts. Comparison of changes in mRNA levels of genes misregulated in each histone
ted with TSA. Relative expression levels are shown using the scale of the red-green
sents up-regulated genes and green represents down-regulated genes.
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list of TSA treated up-regulated genes revealed that many are lo-
cated in subtelomeric regions (Fig. 4). Genes within 20 kb of telo-
meres appear to be enriched for these upregulated genes after TSA
treatment. 14.5% of genes between 0 and 20 kb from the telomeres
are activated by TSA treatment (Table S2). We also note that nines
genes downregulated by TSA treatment appear to be randomly dis-
tributed throughout the genome. A growing body of evidence indi-
cates that histone chaperones can also participate in telomeric
silencing [41]. Our previous study revealed that the histone variant
chaperone Chz1 can regulate H2B ubiquitination and H3K79 di-
methylation to regulate subtelomeric silencing [28]. The complex
transcriptome proﬁles of the chz1 null mutant before and after
TSA treatment lead us to test whether subtelomeric anti-silencing
defects in chz1 mutant are affected by TSA treatment. To our sur-
prise, we still observed signiﬁcant enrichment of up-regulated
genes in subtelomeric regions in the chz1 null after TSA treatment,
similar to the transcription proﬁle of WT cells treated with TSA
(Fig. 4). There is no signiﬁcant difference however, for rtt106 and
asf1mediated telomere silencing defects after TSA treatment (data
not shown).Fig. 4. (A) Genes with signiﬁcantly altered expression in cells lacking CHZ1 before and
analysis was done on genes with signiﬁcant differential expression (down-regulated or u
was determined and these distances were grouped into 5-kb bins and plotted as a functio
distances for all ORFs plotted at one-third scale on the y-axis. (B) The association of S
antibody, followed by qPCR. The relative enrichment ratio for each probes are plotted. An
normalize signal enrichment. Error bars show the standard deviation from three indepeYeast Sir2 is a heterochromatin component which promotes
transcriptional silencing at telomeres [42]. To investigate if TSA
based rescue of chz1 mediated telomere anti-silencing defects is
mediated by the SIR proteins, we chose Sir2 as a marker protein
for telomeric silencing proteins bound to telomeric regions. Chro-
matin immunoprecipitation (ChIP) was used to compare the pat-
terns of Sir2 association in WT without TSA treatment and WT
with TSA treatment. Primer sets targeting DNA from 0.5 to 4.1 kb
from the telomere ends were used to amplify the immunoprecipi-
tated DNA. Results from these ChIP experiments reveal that the
association of Sir2 with telomeric DNA is signiﬁcantly decreased
after TSA treatment (P < 0.05) (Fig. 4B). Consistent with our previ-
ous study, the association of Sir2p with telomeres is not affected by
the absence of Chz1 in both telomere-distal and proximal regions.
Most interestingly, in the chz1 deletion mutant strain, TSA treat-
ment dramatically decreases the association of Sir2 with telomeric
DNA (P < 0.05). Treatment of the cells with TSA removes Sir2 from
the telomeres, generating the anti-silencing phenotype and antag-
onizing the silencing phenotype seen in chz1 deletion mutants. To-
gether, these results demonstrate that TSA can antagonize
subtelomeric anti-silencing defects in the chz1 mutant, likelyafter TSA treatment map to distinct chromosome regions. Chromosome position
p-regulated more than twofold). For each gene, the distance to the nearest telomere
n of telomeric distance. The shaded histograms indicate the distribution of telomeric
ir2 with subtelomeric chromatin regions was determined by ChIP using anti-myc
amplicon within the non-promoter IGRi YMR325Wwas used as an internal control to
ndent biological replicates.
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histone acetylation.
The establishment, maintenance and inheritance of subtelo-
mere silencing in budding yeast requires several mechanisms
including the incorporation of histone variant H2A.Z and various
trans-acting factors [22,43,44]. The loss of H2A.Z results in the
spreading of SIR proteins toward euchromatin [45–47]. In this
study, we have shown that TSA treatment results in decreased lev-
els of Sir2 at subtelomeric regions. We speculate that removal of
Sir2 at subtelomeric regions after TSA treatment could render the
associated histones more susceptible to acetylation and thus in-
crease gene expression. Moreover, the decrease in Sir2 protein at
telomeres can, in part, explain how TSA is able to speciﬁcally
antagonize of subtelomeric anti-silencing defects in the chz1 mu-
tant. Further investigation into the molecular mechanisms by
which TSA modulates speciﬁc histone deacetylation to overcome
chz1 null mediated subtelomeric anti-silencing defects will yield
insight into the functional interplay between histone chaperones
and histone acetylation in chromatin boundary formation.
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